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Introduction
Osteoarthritis is the most common joint disease 
in the world, and it is rapidly becoming a major 
public health issue among the aged population. The 
initiating event of osteoarthritis is still unknown 
and believed to be multifactorial. It is characterized 
by quantitative and qualitative destructive changes 
in the architecture and composition of all the joint 
structures. Chondrocytes are the only cell type that 
is present in mature cartilage, and is responsible for 
repairing the damaged tissue. 
In vitro and in vivo studies on chondrocytes and 
experimental animal model treated with sympto-
matic slow-acting drugs, such as glucosamine com-
pounds, have suggested their capability to inhibit 
cartilage destruction and to promote disease sup-
pression (Scotto d’Abusco et al., 2007). However, 
their exact mechanisms have not been completely 
elucidated. In order to describe more clearly the 
effects of glucosamine compounds on cartilage biol-
ogy, we have analyze whether glucosamine sulphate 
(GS) is able to modify the protein expression profi le 
of normal chondrocytes stimulated with interleukin-
1β (IL-1β) and/or to modify the protein expression 
profi le of osteoarthritic chondrocytes in basal con-
dition.
Materil and methods
Chondrocytes were obtained from 3 osteoar-
thritic patients undergoing joint replacement, and 
from 1 healthy donor. Normal chondrocytes were 
treated with GS 10mM and IL-1β 10ng/mL, while 
osteoarthritic chondrocytes were treated with GS 
10mM alone. Whole cell proteins were isolated 24 
hours after cellular stimulation and resolved by two-
dimensional electrophoresis (2-DE) as previously 
described (Ruiz-Romero et al; 2005). The gels were 
stained with SYPRORuby and digitized using a 
CCD. The images analysis was performed using the 
PDQuest 7.3.1 computer software. Using PDQuest 
tools, protein spots were enumerated, quantifi ed and 
characterized with respect to their molecular mass 
and isoelectric point by bilinear interpolation be-
tween landmark features on each image. Protein ex-
pression data from each gel were normalized for the 
total density present in the gel images. Some of the 
altered proteins were identifi ed by matrix-assisted 
laser desorption/ionization-time of fl ight (MALDI-
TOF) or MALDI-TOF/TOF mass spectrometry. 
Results
We examined a mean of 500 protein spots that 
were present in each gel. Both qualitative and quan-
titative changes in protein expression patterns be-
tween controls (normal chondrocytes stimulated 
with IL-1β and osteoarthritic chondrocytes in basal 
condition) and treated cells (normal chondrocytes 
stimulated with IL-1β + GS 10 mM and osteoarthrit-
ic chondrocytes stimulated with GS 10 mM alone) 
were studied. In normal chondrocytes, 39 protein 
spots were modulated by GS treatment compare to 
the control condition. In osteorthritic chondrocytes, 
11 protein spots were found to be statistically altered 
in GS treated cells compare to the untreated cells 
(p<0.05). Identifi ed proteins are listed in the Table. 
The most of them (36,8%) are involved in cellular 
metabolism (in particular glycolysis), protein fold-
ing (36,8%) and stress response (10,5%). 
Conclusions
This preliminary study describes the differences 
between the protein expression profi les of normal 
and osteoarthritic chondrocytes treated with glu-
cosamine sulphate. We have identifi ed novel molec-
ular targets that maybe could explain the benefi cent 
effects of glucosamine sulphate in osteoarthritic 
treatment.
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Protein identifi ed in normal chondrocytes
NAME Protein ID Ratio IL-1β +GS/IL-1β SSP (PDQuest)
Protein disulfi de-isomerase precursor  PDIA1 6.39 611
78 kDa glucose-regulated protein precursor  GRP78 7.89 802
Heat shock cognate 71 kDa protein  HSP7C 7.57 1820
Protein disulfi de-isomerase A3 precursor  PDIA3 10.89 2610
Protein disulfi de-isomerase A3 precursor  PDIA3 10.00 3601
Superoxide dismutase [Mn], mitochondrial precursor SODM 0.17 7002
Annexin A2 ANXA2 4.01 7201
Annexin A2 ANXA2 2.63 7210
Alpha-enolase ENOA 0.50 7402
Pyruvate kinase isozymes M1/M2 KPYM 0.61 8607
Protein identifi ed in osteoarthritic chondrocytes
NAME Protein ID Ratio GS/untreated cells SSP (PDQuest)
14-3-3 protein theta (14-3-3 protein tau) 1433T 6.53 206
Calumenin precursor (Crocalbin) CALU -2.27 602
Endoplasmin precursor (GRP94) ENPL 2.70 1701
Endoplasmin precursor (GRP94) ENPL -2.1 1702
L-lactate dehydrogenase B chain LDHB 2.73 4302
Isocitrate dehydrogenase [NADP] cytoplasmic IDH1 -1.4 7605
Inosine-5’-monophosphate dehydrogenase 2+ 
Glucose-6-phosphate 1-dehydrogenase
IMDH2+ 
G6PD No in GS 7706
Destrin (Actin-depolymerizing factor) DEST -14.3 9002
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Introducción
La mitocondria esta involucrada en numerosos 
procesos celulares, y se ha demostrado que disfun-
ciones mitocondriales están asociadas con apoptosis, 
envejecimiento y numerosas condiciones patológi-
cas, incluyendo la osteoartritis (OA). El objetivo de 
este trabajo es analizar los cambios en las proteínas 
mitocondriales características de condrocitos OA 
mediante técnicas de proteómica.
